Evaluation of suppressor behavior of guanidine‐derived metformin and galegine as novel potential drugs for cancer treatment: an in silico study
Biotechnology and Applied Biochemistry · 2024
DOI: 10.1002/bab.2636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2024. Verfasst von Mohammad Behrouzi Varjovi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Agriculture, Department of Crop Production and Genetics, University of Mohaghegh Ardabili, Ardabil, Iran. Hauptthemen laut MEDLINE: Metformin, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
There are some natural products from plants that can prevent and treat disease. Metformin, a derivative of galegine, is the basic drug to treat diabetes. Moreover, this molecule has anticancer properties that inhibit cancer cell growth and proliferation. In this study, the main interactions of galegine and metformin with various cancer‐involved proteins, including mitochondrial alpha‐glycerophosphate dehydrogenase, yeast NADH dehydrogenase, and transforming growth factor‐β1, were surveyed by molecular docking and molecular dynamics simulations. The results showed that each of the proteins makes complexes with the ligands via favorable non‐bonded interactions, especially hydrogen bond interactions. There is greater stability for complexes containing galegine based on the root mean square deviation results. The higher structure compactness is also found in galegine receptors than in metformin receptors. Calculation of Δ G binding , using the MM/PBSA methodology, shows that the binding energy values for metformin and galegine in interaction with each of the receptors are almost the same, and galegine has similar binding properties with metformin in interaction with the studied protein receptors. Therefore, galegine, a natural ingredient with better binding properties to cancer‐involved proteins than metformin (with various side effects), can be applied as a new drug for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Agriculture, Department of Crop Production and Genetics, University of Mohaghegh Ardabili, Ardabil, Iran.
- Faculty of Engineering, Department of Chemical Engineering, University of Bonab, Bonab, Iran.
ORCID-Profile: Mohammad Behrouzi Varjovi
Zitieren
APA
Behrouzi Varjovi, M., Asghari-Zakaria, R., & Hosseinzadeh, G. (2024). Evaluation of suppressor behavior of guanidine‐derived metformin and galegine as novel potential drugs for cancer treatment: an in silico study. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2636
Vancouver
Behrouzi Varjovi M, Asghari-Zakaria R, Hosseinzadeh G. Evaluation of suppressor behavior of guanidine‐derived metformin and galegine as novel potential drugs for cancer treatment: an in silico study. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2636
BibTeX
@article{BehrouziVarjovi2024,
author = {Behrouzi Varjovi, Mohammad and Asghari-Zakaria, Rasool and Hosseinzadeh, Ghader},
title = {Evaluation of suppressor behavior of guanidine‐derived metformin and galegine as novel potential drugs for cancer treatment: an in silico study},
journal = {Biotechnology and Applied Biochemistry},
year = {2024},
doi = {10.1002/bab.2636}
}
EUVIMED